Blog

Leveraging COVID-19 public-private partnerships for TB vaccine development

By Ryan M. Kane, MD, MPH and Hunter Spencer, DO | February 8, 2022

The past few years have created a paradigm shift in the way we globally respond to and address communicable diseases. Though we remain in the midst of the COVID-19 pandemic, several novel vaccine candidates have been developed, manufactured, studied, approved, distributed, and administered to millions of individuals around the world in less than one year.…

Read More...

December 2021 Publications

By WGNV | January 5, 2022

A compilation of articles related to TB vaccine R&D published in December 2021.

Read More...

November 2021 Publications

By WGNV | December 8, 2021

A compilation of articles published in November 2021 related to TB vaccine R&D

Read More...

October 2021 Publications

By WGNV | November 4, 2021

A compilation of articles related to TB vaccine R&D published in October 2021.

Read More...

September 2021 Publications

By WGNV | October 5, 2021

A compilation of articles related to TB vaccine research and development published in September 2021.

Read More...

August 2021 Publications

By WGNV | September 14, 2021

A compilation of articles related to TB vaccine R&D published in August 2021.

Read More...

July 2021 Publications

By WGNV | August 9, 2021

A compilation of articles related to TB vaccine R&D published in July 2021.

Read More...

June 2021 Publications

By WGNV | July 12, 2021

A compilation of articles related to TB vaccine R&D published in June 2021.

Read More...

May 2021 Publications

By WGNV | June 9, 2021

A compilation of articles related to TB vaccine R&D published in May 2021.

Read More...

M72/ AS01E Works: Now What?

By Hunter Spencer, DO | May 25, 2021

We recently discussed M72/AS01E and the exciting data suggesting its efficacy in preventing progression of TB disease after people had already been exposed to TB. Today, we will put these findings into context. Some of the excitement regarding this trial stems from the novelty of its findings. Dr. Ann Ginsberg is a TB researcher working…

Read More...

Guest posts published on this blog reflect the views of their authors and persons interviewed and do not necessarily reflect the views of the Stop TB Partnership Working Group on New TB Vaccines.